Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
314.00
-0.28 (-0.09%)
At close: Jan 30, 2026, 4:00 PM EST
318.02
+4.02 (1.28%)
After-hours: Jan 30, 2026, 7:38 PM EST
PRAX Stock Forecast
Stock Price Forecast
The 14 analysts that cover PRAX stock have a consensus rating of "Strong Buy" and an average price target of $519.79, which forecasts a 65.54% increase in the stock price over the next year. The lowest target is $73 and the highest is $1,245.
Price Target: $519.79 (+65.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 8 | 9 | 10 | 10 |
| Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $340 → $1,245 | Strong Buy | Maintains | $340 → $1,245 | +296.50% | Jan 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $450 → $1,200 | Buy | Maintains | $450 → $1,200 | +282.17% | Jan 28, 2026 |
| Wedbush | Wedbush | Sell Maintains $83 → $95 | Sell | Maintains | $83 → $95 | -69.75% | Jan 12, 2026 |
| BTIG | BTIG | Strong Buy Maintains $507 → $843 | Strong Buy | Maintains | $507 → $843 | +168.47% | Dec 29, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $750 | Buy | Maintains | $250 → $750 | +138.85% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
43.72K
from 8.55M
Decreased by -99.49%
Revenue Next Year
6.60M
from 43.72K
Increased by 15,003.90%
EPS This Year
-13.31
from -10.21
EPS Next Year
-12.98
from -13.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 630,000 | 72.2M | ||||
| Avg | 43,717 | 6.6M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -92.6% | 164,999.8% | ||||
| Avg | -99.5% | 15,003.9% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -12.58 | -5.54 | ||||
| Avg | -13.31 | -12.98 | ||||
| Low | -14.00 | -20.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.